Related references
Note: Only part of the references are listed.Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia
Jenny Q. D. Tran et al.
PLATELETS (2020)
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
Shin-Yi Lin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Overexpressed microRNA-103a-3p inhibits acute lower-extremity deep venous thrombosis via inhibition of CXCL12
Shaoliang Sun et al.
IUBMB LIFE (2020)
Clinical manifestation of hemophilia A in the absence of mutations in the F8 gene that encodes FVIII: role of microRNAs
Katarzyna Jankowska et al.
TRANSFUSION (2020)
IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p
Yunhong Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
Marco Witkowski et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)
Rami A. Al-Horani
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty The FOXTROT Randomized Clinical Trial
Jeffrey I. Weitz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
M. Jansson et al.
THROMBOSIS RESEARCH (2020)
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Sarah Bajan et al.
CELLS (2020)
Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
[Anonymous]
ANNALS OF INTERNAL MEDICINE (2020)
Identification of a Plasma MicroRNA Profile Associated With Venous Thrombosis
Alba Rodriguez-Rius et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human Primate
Michael Wallisch et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2020)
MicroRNAs in venous thrombo-embolism
Anju Angelina Hembrom et al.
CLINICA CHIMICA ACTA (2020)
Role of microRNAs in Venous Thromboembolism
Vania M. Morelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
RNA-Targeted Therapies and High-Throughput Screening Methods
Siran Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of microRNAs in Hemophilia and Thrombosis in Humans
Katarzyna I. Jankowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The powerful world of antisense oligonucleotides: From bench to bedside
Anais M. Quemener et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
RNA therapeutics on the rise
Feng Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis
Jinghan Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
A Foundational Study for NormalF8-Containing Mouse Models for the miRNA Regulation of Hemophilia A: Identification and Analysis of Mouse miRNAs that Downregulate the MurineF8Gene
Katarzyna Jankowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
Alexis Forterre et al.
CANCERS (2020)
Emerging Roles of RNA 3′-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders
Jamie Nourse et al.
BIOMOLECULES (2020)
miR-374b-5p is increased in deep vein thrombosis and negatively targets IL-10
Yunhong Zhang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
The contact activation system as a potential therapeutic target in patients with COVID-19
Joseph J. Shatzel et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKETAF and XANTUS
A. John Camm et al.
EUROPACE (2019)
MicroRNAs as potential regulators of platelet function and bleeding diatheses
Ascension M. De Los Reyes-Garcia et al.
PLATELETS (2019)
Intrinsic Pathway of Coagulation and Thrombosis: Insights From Animal Models
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance
Hiroshi Inoue et al.
JOURNAL OF CARDIOLOGY (2019)
FactorXI and recurrent venous thrombosis: an observational cohort study
Paul A. Kyrle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Association of recurrent venous thromboembolism and circulating microRNAs
Xiao Wang et al.
CLINICAL EPIGENETICS (2019)
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Yi-Hsin Chan et al.
CHEST (2019)
Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis
Ichiro Sakuma et al.
HEART AND VESSELS (2019)
MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1
Wenbin Wang et al.
MICROVASCULAR RESEARCH (2019)
RNA-based diagnostic and therapeutic strategies for cardiovascular disease
Dongchao Lu et al.
NATURE REVIEWS CARDIOLOGY (2019)
The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials
Emma P. DeLoughery et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
The predictive value of circulating microRNAs for venous thromboembolism diagnosis: A systematic review and diagnostic meta-analysis
Qian Xiang et al.
THROMBOSIS RESEARCH (2019)
Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users
Carlos Sostres et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis
Xiaolong Du et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study
Lars J. Kjerpeseth et al.
PLOS ONE (2019)
Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI
Benjamin Georgi et al.
STROKE (2019)
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group
Alan N. Barkun et al.
ANNALS OF INTERNAL MEDICINE (2019)
International Consensus Guidelines for Nonvariceal Gastrointestinal Bleeding: A Step Forward
Angel Lanas
ANNALS OF INTERNAL MEDICINE (2019)
MiR-205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression
Li-Li Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass
Valerie Pireaux et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
Karen P. Alexander et al.
AMERICAN HEART JOURNAL (2019)
Apixaban Levels in Octogenarian Patients with Non-valvular Atrial Fibrillation
Ran Nissan et al.
DRUGS & AGING (2019)
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Kioomars Saliminejad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin
Corrie L. Gallant-Behm et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
RNA therapy: Are we using the right molecules?
Ai-Ming Yu et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Re-Engineering RNA Molecules into Therapeutic Agents
Martin Egli et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice
Toshiaki Shirai et al.
BLOOD ADVANCES (2019)
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
Jan Beyer-Westendorf et al.
THROMBOSIS JOURNAL (2019)
Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis
Vikrant Rai et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2019)
Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system
Todd C. Villines et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)
Interplay between miRNAs and human diseases
Prosenjit Paul et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The search for new antithrombotic mechanisms and therapies that may spare hemostasis
Edward F. Plow et al.
BLOOD (2018)
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al.
BLOOD (2018)
Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
Niklas W. Andersson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk
W. Zhu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Recent advances in the discovery and development of factor XI/XIa inhibitors
Rami A. Al-Horani et al.
MEDICINAL RESEARCH REVIEWS (2018)
microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
Ana B. Arroyo et al.
THROMBOSIS RESEARCH (2018)
Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2′-MOE-Modified Antisense Oligonucleotide
Padmakumar Narayanan et al.
TOXICOLOGICAL SCIENCES (2018)
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
Brandon K. Martinez et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Large-scale identification of functional microRNA targeting reveals cooperative regulation of the hemostatic system
J. Nourse et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Plasma microRNA markers of upper limb recovery following human stroke
Matthew A. Edwardson et al.
SCIENTIFIC REPORTS (2018)
Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns
Sonia Manca et al.
SCIENTIFIC REPORTS (2018)
von Willebrand factor rescued by miR-24 inhibition facilitates the proliferation and migration of osteosarcoma cells in vitro
Ling Liu et al.
BIOSCIENCE REPORTS (2018)
Effect of miR-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1 (Publication with Expression of Concern. See vol. 42, pg. 1, 2022)
Ke-Cheng Tang et al.
BIOSCIENCE REPORTS (2018)
Regulation of cell-type-specific transcriptomes by microRNA networks during human brain development
Tomasz J. Nowakowski et al.
NATURE NEUROSCIENCE (2018)
Transcriptome 3′ end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma
Anton Ogorodnikov et al.
NATURE COMMUNICATIONS (2018)
Plasma Levels of microRNA-221 (miR-221) are Increased in Patients with Acute Pulmonary Embolism
Tingwei Liu et al.
MEDICAL SCIENCE MONITOR (2018)
Diagnostic value of circulating microRNA-27a/b in patients with acute pulmonary embolism
Qian Wang et al.
INTERNATIONAL ANGIOLOGY (2018)
Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events
Meir Preis et al.
BLOOD (2017)
MiR-340 Regulates Fibrinolysis and Axon Regrowth Following Sciatic Nerve Injury
Shiying Li et al.
MOLECULAR NEUROBIOLOGY (2017)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Circulating MicroRNAs as Novel Biomarkers of Stenosis Progression in Asymptomatic Carotid Stenosis
Sandra Dolz et al.
STROKE (2017)
Risk of gastrointestinal bleeding during anticoagulant treatment
Aitor Lanas-Gimeno et al.
EXPERT OPINION ON DRUG SAFETY (2017)
The Diagnostic Value of Serum miRNA-221-3p, miRNA-382-5p, and miRNA-4271 in Ischemic Stroke
Yaru Wang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Circulating microRNA expression and their target genes in deep vein thrombosis A systematic review and bioinformatics analysis
Zhiyun Jiang et al.
MEDICINE (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Thrombophilia Testing and Venous Thrombosis
Jean M. Connors
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
Ricardo Titze-de-Almeida et al.
PHARMACEUTICAL RESEARCH (2017)
Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension
Sabine Kossmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
Myung-Jin Cha et al.
STROKE (2017)
Assessment of the Effects of 2'-Methoxyethyl Antisense Oligonucleotides on Platelet Count in Cynomolgus Nonhuman Primates
Scott P. Henry et al.
NUCLEIC ACID THERAPEUTICS (2017)
Kinetics of Circulating MicroRNAs in Response to Cardiac Stress in Patients With Coronary Artery Disease
Felix Jansen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The Diagnostic Value of Serum miRNA-221-3p, miRNA-382-5p, and miRNA-4271 in Ischemic Stroke
Yaru Wang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells
Renata C. Costa de Freitas et al.
FRONTIERS IN PHARMACOLOGY (2017)
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
Jennifer M. Beierlein et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
MicroRNA-145 Impedes Thrombus Formation via Targeting Tissue Factor in Venous Thrombosis
Anita Sahu et al.
EBIOMEDICINE (2017)
Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens
Ana B. Arroyo et al.
SCIENTIFIC REPORTS (2017)
Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease
Julien Faccini et al.
SCIENTIFIC REPORTS (2017)
Identification of coagulation gene 3′UTR variants that are potentially regulated by microRNAs
Carla Y. Vossen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin
David J. Cangemi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy
Marco Heestermans et al.
THROMBOSIS JOURNAL (2017)
Circulating MicroRNA-145 is Associated with Acute Myocardial Infarction and Heart Failure
Ming Zhang et al.
CHINESE MEDICAL JOURNAL (2017)
MicroRNA Biomarkers and Platelet Reactivity The Clot Thickens
Nicholas Sunderland et al.
CIRCULATION RESEARCH (2017)
Overexpression of miR-24 Is Involved in the Formation of Hypocoagulation State after Severe Trauma by Inhibiting the Synthesis of Coagulation Factor X
Lu-Jia Chen et al.
DISEASE MARKERS (2017)
Signature of circulating microRNAs in patients with acute heart failure
Ekaterina S. Ovchinnikova et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
MicroRNA as Biomarkers and Diagnostics
Jin Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
Marco Witkowski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
MiR-128 and miR-125 regulate expression of coagulation Factor IX gene with nonsense mutation by repressing nonsense-mediated mRNA decay
Gang Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
How I treat patients with inherited bleeding disorders who need anticoagulant therapy
Karlyn Martin et al.
BLOOD (2016)
Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets
Jesse W. Rowley et al.
BLOOD (2016)
Drosha and Dicer: Slicers cut from the same cloth
Sisi Li et al.
CELL RESEARCH (2016)
Circulating miR-181a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction
Jianbing Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
MicroRNA Regulation of Atherosclerosis
Mark W. Feinberg et al.
CIRCULATION RESEARCH (2016)
Global Burden of Thrombosis Epidemiologic Aspects
Aaron M. Wendelboe et al.
CIRCULATION RESEARCH (2016)
Anticoagulants: What Is New and What Is the Standard?
L. J. Lesko
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
An update on the pharmaceutical management of thrombosis
Benilde Cosmi
EXPERT OPINION ON PHARMACOTHERAPY (2016)
MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10
Jibin Lin et al.
FASEB JOURNAL (2016)
A germline variant affects putative miRNA-binding sites at the F8 3′UTR and acts as a potential haemophilia A phenotype modifier in Southern Brazilian patients
C. Rosset et al.
HAEMOPHILIA (2016)
The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy
Allison P. Wheeler et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor
H. O. Ali et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
Allison E. Burnett et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism
Thorsten Kessler et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Upregulation of miR-483-3p contributes to endothelial progenitor cells dysfunction in deep vein thrombosis patients via SRF
Lingshang Kong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
A microRNA switch regulates the rise in hypothalamic GnRH production before puberty
Andrea Messina et al.
NATURE NEUROSCIENCE (2016)
Processing and transcriptome expansion at the mRNA 3' end in health and disease: finding the right end
Anton Ogorodnikov et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)
Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis
Xiao Wang et al.
THROMBOSIS AND HAEMOSTASIS (2016)
MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism
Xin Zhou et al.
THROMBOSIS RESEARCH (2016)
Endothelial progenitor cells accelerate the resolution of deep vein thrombosis
Wen-Dong Li et al.
VASCULAR PHARMACOLOGY (2016)
Deep vein thrombosis is accurately predicted by comprehensive analysis of the levels of microRNA-96 and plasma D-dimer
Xuesheng Xie et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets
Mao Luo et al.
SCIENTIFIC REPORTS (2016)
Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus
B. -S. Kim et al.
HLA (2016)
miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study
Sofie Solvsten Sorensen et al.
TRANSLATIONAL NEURODEGENERATION (2016)
'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'
C. Perez-Sanchez et al.
SCIENTIFIC REPORTS (2016)
MicroRNAs 10a and 10b Regulate the Expression of Human Platelet Glycoprotein Ibα for Normal Megakaryopoiesis
Zuping Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
MicroRNA in atherothromobosis: is it useful as a disease marker?
Satoshi Fujii et al.
THROMBOSIS JOURNAL (2016)
MicroRNA-15b Modulates Molecular Mediators of Blood Induced Arthropathy in Hemophilia Mice
Dwaipayan Sen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)
Aaron R. Folsom et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein
Trang T. Vu et al.
BLOOD (2015)
Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice
Yuhang Zhou et al.
BLOOD (2015)
Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding
Tian-Quan Cai et al.
BLOOD COAGULATION & FIBRINOLYSIS (2015)
miR340 Suppresses the Stem-like Cell Function of Glioma-Initiating Cells by Targeting Tissue Plasminogen Activator
Daisuke Yamashita et al.
CANCER RESEARCH (2015)
Circulating miR-145 is associated with plasma high-sensitivity C-reactive protein in acute ischemic stroke patients
Lihua Jia et al.
CELL BIOCHEMISTRY AND FUNCTION (2015)
MicroRNA: master controllers of intracellular signaling pathways
Pak-Yin Lui et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Investigating the Role of the Post-transcriptional Gene Regulator MiR-24-3p in the Proliferation, Migration and Apoptosis of Human Arterial Smooth Muscle Cells in Arteriosclerosis Obliterans
Xiao-feng Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Dicer Cleavage by Calpain Determines Platelet microRNA Levels and Function in Diabetes
Amro Elgheznawy et al.
CIRCULATION RESEARCH (2015)
Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants
Angel Lanas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Validated MicroRNA Target Databases: An Evaluation
Yun Ji (Diana) Lee et al.
DRUG DEVELOPMENT RESEARCH (2015)
Upregulation of MicroRNA-126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2
Qingyou Meng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Factor XII: a novel target for safe prevention of thrombosis and inflammation
E. Kenne et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
G. Agnelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
MicroRNA deregulation in symptomatic carotid plaque
Pierre Maitrias et al.
JOURNAL OF VASCULAR SURGERY (2015)
NON-CODING RNA Towards a molecular understanding of microRNA-mediated gene silencing
Stefanie Jonas et al.
NATURE REVIEWS GENETICS (2015)
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Biological and Analytical Variations of 16 Parameters Related to Coagulation Screening Tests and the Activity of Coagulation Factors
Qian Chen et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
Sam Schulman et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals
Irina Starikova et al.
THROMBOSIS RESEARCH (2015)
Platelet MicroRNAs: An Overview
Neetu Dahiya et al.
TRANSFUSION MEDICINE REVIEWS (2015)
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
Neena S. Abraham et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
Neena S. Abraham et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
Soren Ottosen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
MicroRNAs in hemostasis
R. Teruel-Montoya et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Competition between target sites of regulators shapes post-transcriptional gene regulation
Marvin Jens et al.
NATURE REVIEWS GENETICS (2015)
Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates
Trinna L. Cuellar et al.
NUCLEIC ACIDS RESEARCH (2015)
Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene
Tewarit Sarachana et al.
PLOS ONE (2015)
Prediction of long-term outcome after acute myocardial infarction using circulating miR-145
Yu-Mei Dong et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2015)
MicroRNAs in vascular aging and atherosclerosis
Rossella Menghini et al.
AGEING RESEARCH REVIEWS (2014)
Factor XI Regulates Pathological Thrombus Formation on Acutely Ruptured Atherosclerotic Plaques
Maurits L. van Montfoort et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells
Sufang Li et al.
ATHEROSCLEROSIS (2014)
Factor XII inhibition reduces thrombus formation in a primate thrombosis model
Anton Matafonov et al.
BLOOD (2014)
Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits
Jonathan W. Yau et al.
BLOOD (2014)
miR-96 and miR-330 overexpressed and targeted AQP5 in lipopolysaccharide-induced rat lung damage of disseminated intravascular coagulation
Yanfen Zhang et al.
BLOOD COAGULATION & FIBRINOLYSIS (2014)
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Sam Schulman et al.
CIRCULATION (2014)
Serum miR-122 levels are related to coagulation disorders in sepsis patients
Hui-Juan Wang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Development of microRNA therapeutics is coming of age
Eva van Rooij et al.
EMBO MOLECULAR MEDICINE (2014)
Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency
P. James et al.
HAEMOPHILIA (2014)
MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor
Sufang Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Let-7g Improves Multiple Endothelial Functions Through Targeting Transforming Growth Factor-Beta and SIRT-1 Signaling
Yi-Chu Liao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women
B. Siegerink et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
MicroRNAs in Atherosclerosis
Ali A. Hosin et al.
JOURNAL OF VASCULAR RESEARCH (2014)
Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction
Jiansuo Zhou et al.
MOLECULAR MEDICINE REPORTS (2014)
The multilayered complexity of ceRNA crosstalk and competition
Yvonne Tay et al.
NATURE (2014)
Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver
Salam Salloum-Asfar et al.
PLOS ONE (2014)
MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection
Ewelina Maria Kaluzna
REVIEWS IN MEDICAL VIROLOGY (2014)
A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Magnus Larsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice
Federica Sala et al.
THROMBOSIS AND HAEMOSTASIS (2014)
ELAVL1 Modulates Transcriptome-wide miRNA Binding in Murine Macrophages
Yi-Chien Lu et al.
CELL REPORTS (2014)
Epidemiologic and clinical data linking factors XI and XII to thrombosis
Nigel S. Key
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
Martin H. Prins et al.
LANCET HAEMATOLOGY (2014)
Molecular Mechanisms of RNA Interference
Ross C. Wilson et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 42 (2013)
Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in Primates
Jeffrey R. Crosby et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans
Guangwen Long et al.
BMC NEUROLOGY (2013)
Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban
Inna Y. Gong et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Differential MicroRNA Expression Profiles in Peripheral Arterial Disease
Philip W. Stather et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond
Sven Danckwardt et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
MicroRNAs in platelet production and activation
L. C. Edelstein et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Assessing bleeding risk in patients taking anticoagulants
Marwa Shoeb et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Shin-ichiro Ohno et al.
MOLECULAR THERAPY (2013)
Argonaute proteins: functional insights and emerging roles
Gunter Meister
NATURE REVIEWS GENETICS (2013)
Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA
Sarah L. DeVos et al.
NEUROTHERAPEUTICS (2013)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Congenital Factor XI Deficiency: An Update
Stefano Duga et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
Maurits L. van Montfoort et al.
THROMBOSIS AND HAEMOSTASIS (2013)
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
Olivia Perwitasari et al.
PHARMACEUTICALS (2013)
RNAi-based nanomedicines for targeted personalized therapy
Ala Daka et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
A Genome-Wide Association Study Identifies KNG1 as a Genetic Determinant of Plasma Factor XI Level and Activated Partial Thromboplastin Time
Maria Sabater-Lleal et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
Husam S. Younis et al.
BLOOD (2012)
Dissection of human MiRNA regulatory influence to subpathway
Xia Li et al.
BRIEFINGS IN BIOINFORMATICS (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Eduard Hergenreider et al.
NATURE CELL BIOLOGY (2012)
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Ryszard Kole et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC
Marc R. Fabian et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells
Alexandre Marchand et al.
PLOS ONE (2012)
Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction
Guangwen Long et al.
PLOS ONE (2012)
Factor XI: Hemostasis, Thrombosis, and Antithrombosis
Rong He et al.
THROMBOSIS RESEARCH (2012)
Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol
Xiao Sun et al.
THROMBOSIS JOURNAL (2012)
miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study
Emma Raitoharju et al.
ATHEROSCLEROSIS (2011)
MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction
Benjamin Meder et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells
Nitin Patel et al.
BIOCHEMICAL JOURNAL (2011)
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
Alexey S. Revenko et al.
BLOOD (2011)
Assessment of Plasma miRNAs in Congestive Heart Failure
Yasue Fukushima et al.
CIRCULATION JOURNAL (2011)
Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells BIOLOGICAL CORRELATES AND MOLECULAR TARGETS
Mineko Terao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells
Xiaoxi Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNA-18a Enhances the Interleukin-6-mediated Production of the Acute-phase Proteins Fibrinogen and Haptoglobin in Human Hepatocytes
Matthias Brock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome
R. Teruel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism
Junjie Xiao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
p38 MAPK Controls Prothrombin Expression by Regulated RNA 3′ End Processing
Sven Danckwardt et al.
MOLECULAR CELL (2011)
MicroRNAs can generate thresholds in target gene expression
Shankar Mukherji et al.
NATURE GENETICS (2011)
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Eric Huntzinger et al.
NATURE REVIEWS GENETICS (2011)
MECHANISMS OF DISEASE The Hemostatic System as a Modulator of Atherosclerosis
Julian Ilcheff Borissoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Synergistic Post-Transcriptional Regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 Specific Binding
Francesca Megiorni et al.
PLOS ONE (2011)
Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA
Saurabh Singh et al.
PHARMACEUTICAL RESEARCH (2011)
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
Ophira Salomon et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Continuing Education Course #2: Current Understanding of Hemostasis
Andrew J. Gale
TOXICOLOGIC PATHOLOGY (2011)
Regulation of mRNA Translation and Stability by microRNAs
Marc Robert Fabian et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
Hong Zhang et al.
BLOOD (2010)
Regulation of fibrinogen production by microRNAs
Alexandre Fort et al.
BLOOD (2010)
MiR423-5p As a Circulating Biomarker for Heart Failure
Anke J. Tijsen et al.
CIRCULATION RESEARCH (2010)
Circulating MicroRNAs in Patients With Coronary Artery Disease
Stephan Fichtlscherer et al.
CIRCULATION RESEARCH (2010)
Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene
Zhiyong Chen et al.
HUMAN GENETICS (2010)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Rupert Bauersachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Newer antithrombotic drugs
Pranav Sikka et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2010)
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Erik I. Tucker et al.
BLOOD (2009)
Dual role of collagen in factor XII-dependent thrombus formation
Paola E. J. van der Meijden et al.
BLOOD (2009)
Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
Felicitas Muller et al.
CELL (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease
L. Ella et al.
CELL DEATH AND DIFFERENTIATION (2009)
RNAi-based therapeutics-current status, challenges and prospects
Katrin Tiemann et al.
EMBO MOLECULAR MEDICINE (2009)
Controlled delivery of antisense oligonucleotides: a brief review of current strategies
Xiubo Zhao et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Kimberly R. Cordes et al.
NATURE (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Ophira Salomon et al.
BLOOD (2008)
3′ end mRNA processing:: molecular mechanisms and implications for health and disease
Sven Danckwardt et al.
EMBO JOURNAL (2008)
Widespread changes in protein synthesis induced by microRNAs
Matthias Selbach et al.
NATURE (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
Determinants of targeting by endogenous and exogenous microRNAs and siRNAs
Cydney B. Nielsen et al.
RNA (2007)
MicroRNA targeting specificity in mammals: Determinants beyond seed pairing
Andrew Grimson et al.
MOLECULAR CELL (2007)
The evolution of gene regulation by transcription factors and microRNAs
Kevin Chen et al.
NATURE REVIEWS GENETICS (2007)
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and YII
Carine J. M. Doggen et al.
BLOOD (2006)
Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events
David T. Yang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Designing siRNA that distinguish between genes that differ by a single nucleotide
Dianne S. Schwarz et al.
PLOS GENETICS (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Antisense oligonucleotides: From design to therapeutic application
JHP Chan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Cell-type-specific signatures of microRNAs on target mRNA expression
P Sood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Defective thrombus formation in mice lacking coagulation factor XII
T Renné et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice
X Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Genetic determinants of arterial thrombosis
B Voetsch et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Kinetic analysis of the RNAi enzyme complex
B Haley et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Many commonly used siRNAs risk off-target activity
O Snove et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
RISC is a 5′ phosphomonoester-producing RNA endonuclease
J Martinez et al.
GENES & DEVELOPMENT (2004)
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism - A meta-analysis
LA Linkins et al.
ANNALS OF INTERNAL MEDICINE (2003)
Inter-relation of coagulation factors and D-dimer levels in healthy individuals
AV Vlieg et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Regulation of PAI-1 concentration in platelets by systemic administration of antisense oligonucleotides to rats
Z Pawlowska et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Activation of clotting factors XI and IX in patients with acute myocardial infarction
MC Minnema et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
High levels of coagulation factor XI as a risk factor for venous thrombosis.
JCM Meijers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
